Delivery Order SPE2DB25D3202-SPE2DB25FTBEA
- Not listed
- The Defense Logistics Agency awarded a $6,156.84 delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (quantity: 3 units) on August 18, 2025, with completion targeted for August 19, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor serving defense...
- The Defense Logistics Agency awarded a $1,299.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (quantity: 3 units) on July 21, 2025, with completion scheduled for July 22, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger contract vehicle. The pharmaceutical product will be delivered to the company's distribution center in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $2,169.97 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Xulane 150-35 mcg/day contraceptive patches (3-count units). The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,341.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count package) on July 23, 2025, with completion due July 24, 2025. This is an unset-aside, competitively awarded contract performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a transactional purchase of pharmaceutical products within AmerisourceBergen's existing federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,183.01 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (3-count package). This competitively awarded, firm fixed-price delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract does not carry a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,691.42 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count packaging). This is a firm fixed-price, non-set-aside contract with a completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the vendor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $12,219.05 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (quantity of 3 units). This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and completion scheduled for August 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion...
- The Defense Logistics Agency awarded a delivery order valued at $12,138.34 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units). This firm fixed-price, competitively awarded delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,163.04 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units) under a firm fixed price contract type. This non-set-aside award was executed on August 12, 2025, with an ultimate completion date of August 13, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for $4,418.88 to supply Xulane 150-35 mcg/day transdermal patches (quantity: 3 units). This is a firm fixed price delivery order with no set-aside designation, completed competitively under the company's larger indefinite delivery contract with DLA Troop Support Medical. The order is set to be fulfilled by the ultimate completion date of August 13, 2025, with the place of performance in...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBEADelivery Order
The Defense Logistics Agency awarded a $3,145.59 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for Xulane 150-35 mcg/day contraceptive patches (quantity of 3). This contract is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates its extensive capability in delivering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/19/25 |